companydata.dkABACUS MEDICINE A/S
CVR: 28111576
Secondary names: Originalis A/S
ABACUS MEDICINE A/S demonstrates a solid financial trajectory, with revenue increasing from 940.7 million DKK in 2021 to 1.82 billion DKK in 2025. However, profit has fluctuated, peaking at 20 million DKK in 2023 before declining to 7.8 million DKK in 2025, indicating potential margin pressures. The company's equity has steadily improved, reaching 98.5 million DKK in 2025, reflecting a strengthening balance sheet. Positioned within the wholesale distribution of pharmaceuticals and healthcare products, ABACUS MEDICINE is growing but may need to address profitability challenges to sustain its upward momentum.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at drive parallelhandel med lægemidler, handel med medicin vedrørende ikke-registrerede lægemidler og handel med lægemidler i forbindelse med kliniske forsøg samt hermed beslægtet virksomhed.
Location
FinancialsEUR
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.8 mia. | 7.8 mio. | 494.7 mio. | 98.5 mio. | 1590 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area